Trial Profile
The effect of azilsartan medoxomil on the variability of home blood pressure and diabetic vascular complications in patients with type 2 diabetes
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Aug 2016
Price :
$35
*
At a glance
- Drugs Azilsartan (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- 21 Jul 2016 Status changed from recruiting to completed.
- 30 May 2015 Status changed from not yet recruiting to recruiting as per University Hospital Medical Information Network - Japan.
- 26 Mar 2015 New trial record